Published in Circulation on April 25, 2000
Innovative Strategies For Risk Reduction Following CABG | NCT00462436
Darusentan Effect on PET Uptake Heterogeneity (Darusentan) | NCT00738049
Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease (COPD) | NCT01398943
Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. BMJ (2004) 6.31
Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol (2007) 4.13
Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev (2010) 4.02
Effect of exercise training on endothelium-derived nitric oxide function in humans. J Physiol (2004) 3.48
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine. Circulation (2013) 3.45
The assessment of endothelial function: from research into clinical practice. Circulation (2012) 2.68
Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol (2010) 2.68
Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms. J Am Coll Cardiol (2009) 2.58
Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol (2009) 2.49
Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J Clin Invest (2006) 2.40
Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation (2011) 2.32
Nitric oxide and oxidative stress in vascular disease. Pflugers Arch (2010) 2.29
Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Rev Endocr Metab Disord (2010) 2.19
Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag (2005) 2.15
The effect of weight loss and exercise training on flow-mediated dilatation in coronary heart disease: a randomized trial. Chest (2011) 2.15
Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation (2009) 2.09
Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor/apolipoprotein A-I double-knockout mice on Western diet. Circ Res (2005) 2.06
Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation (2009) 2.05
Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications. Br J Clin Pharmacol (2001) 1.97
Understanding the pathophysiology of apical ballooning syndrome: a step closer. Expert Rev Cardiovasc Ther (2014) 1.97
Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am (2005) 1.81
Acute reversal of endothelial dysfunction in the elderly after antioxidant consumption. Hypertension (2012) 1.79
Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS. Am J Physiol Heart Circ Physiol (2008) 1.75
Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol (2006) 1.72
Sprint interval and traditional endurance training induce similar improvements in peripheral arterial stiffness and flow-mediated dilation in healthy humans. Am J Physiol Regul Integr Comp Physiol (2008) 1.62
Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin Med Res (2006) 1.62
"Gum bug, leave my heart alone!"--epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J Dent Res (2010) 1.61
Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score. Eur Heart J (2009) 1.58
Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis (2004) 1.53
Coronary flow reserve in stress-echo lab. From pathophysiologic toy to diagnostic tool. Cardiovasc Ultrasound (2005) 1.53
Periodontal disease and systemic conditions: a bidirectional relationship. Odontology (2006) 1.52
Effect of endothelium-specific insulin resistance on endothelial function in vivo. Diabetes (2008) 1.52
Flow, NO, and atherogenesis. Proc Natl Acad Sci U S A (2003) 1.51
The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease. Curr Cardiol Rev (2010) 1.50
Insulin status and vascular responses to weight loss in obesity. J Am Coll Cardiol (2013) 1.47
Simultaneous Noninvasive Assessment of Systemic and Coronary Endothelial Function. Circ Cardiovasc Imaging (2016) 1.39
Update on nitric oxide-dependent vasodilation in human subjects. Methods Enzymol (2005) 1.34
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. JACC Cardiovasc Interv (2012) 1.30
Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol (2009) 1.27
Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure. Heart (2005) 1.26
Central sympathetic overactivity: maladies and mechanisms. Auton Neurosci (2009) 1.25
Determinants of vascular function in patients with type 2 diabetes. Cardiovasc Diabetol (2012) 1.24
A new class of organic nitrates: investigations on bioactivation, tolerance and cross-tolerance phenomena. Br J Pharmacol (2009) 1.24
Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS). Am Heart J (2008) 1.22
Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med (2006) 1.18
Endothelial abnormalities in adolescents with type 1 diabetes: a biomarker for vascular sequelae? J Pediatr (2010) 1.18
Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis. Ups J Med Sci (2013) 1.18
Redox signaling in cardiovascular health and disease. Free Radic Biol Med (2013) 1.16
Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease. Nephrol Dial Transplant (2008) 1.15
Cardiac syndrome X and microvascular coronary dysfunction. Trends Cardiovasc Med (2012) 1.12
Women and coronary artery disease. Part I: basic considerations. J Tehran Heart Cent (2011) 1.11
Adventures in vascular biology: a tale of two mediators. Philos Trans R Soc Lond B Biol Sci (2006) 1.10
Role of oxidative stress and nitric oxide in atherothrombosis. Front Biosci (2008) 1.10
Mitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stress. Antioxid Redox Signal (2012) 1.10
Endothelial dysfunction over the course of coronary artery disease. Eur Heart J (2013) 1.09
Development of animal models to test the fundamental basis of gene-environment interactions. Obesity (Silver Spring) (2008) 1.09
Contribution of sympathetic activation to coronary vasodilatation during the cold pressor test in healthy men: effect of ageing. J Physiol (2013) 1.08
2014 hypertension recommendations from the eighth joint national committee panel members raise concerns for elderly black and female populations. J Am Coll Cardiol (2014) 1.08
Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group. Circulation (2010) 1.07
Rubidium-82 PET-CT for quantitative assessment of myocardial blood flow: validation in a canine model of coronary artery stenosis. Eur J Nucl Med Mol Imaging (2008) 1.06
Human endothelial dysfunction: EDRFs. Pflugers Arch (2010) 1.04
Evaluation and management of dyslipidemia in patients with HIV infection. J Gen Intern Med (2002) 1.04
Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation. Front Immunol (2013) 1.03
Endothelium and its alterations in cardiovascular diseases: life style intervention. Biomed Res Int (2014) 1.03
Role of PET in the evaluation and understanding of coronary physiology. J Nucl Cardiol (2007) 1.02
Flavonoids: antioxidants against atherosclerosis. Nutrients (2010) 1.01
The effect of L-arginine and creatine on vascular function and homocysteine metabolism. Vasc Med (2009) 0.98
Mechanisms of oxidative stress and vascular dysfunction. Postgrad Med J (2003) 0.98
Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment. Coron Artery Dis (2014) 0.98
Evaluation of the EndoPAT as a Tool to Assess Endothelial Function. Int J Vasc Med (2012) 0.97
Syndrome X and microvascular coronary dysfunction. Circulation (2011) 0.97
Perspectives of Targeting mTORC1-S6K1 in Cardiovascular Aging. Front Physiol (2012) 0.97
Noninvasive assessment of preclinical atherosclerosis. Vasc Health Risk Manag (2006) 0.97
Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction. Int J Mol Sci (2015) 0.96
The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther (2011) 0.96
Role of copper transport protein antioxidant 1 in angiotensin II-induced hypertension: a key regulator of extracellular superoxide dismutase. Hypertension (2012) 0.96
Impaired relaxation of cerebral arteries in the absence of elevated salt intake in normotensive congenic rats carrying the Dahl salt-sensitive renin gene. Am J Physiol Heart Circ Physiol (2010) 0.96
Unacylated ghrelin rescues endothelial progenitor cell function in individuals with type 2 diabetes. Diabetes (2010) 0.95
Risk prediction in cardiovascular disease: the prognostic significance of endothelial dysfunction. Can J Cardiol (2009) 0.95
Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution. Int J Vasc Med (2011) 0.95
Hypoxia and reoxygenation induce endothelial nitric oxide synthase uncoupling in endothelial cells through tetrahydrobiopterin depletion and S-glutathionylation. Biochemistry (2014) 0.94
Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humans. Pharmacogenet Genomics (2012) 0.94
Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries. Clin J Am Soc Nephrol (2008) 0.94
Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study. Heart (2004) 0.94
Endothelial cell-specific reactive oxygen species production increases susceptibility to aortic dissection. Circulation (2014) 0.93
Major depression and coronary flow reserve detected by positron emission tomography. Arch Intern Med (2009) 0.93
A rapid and reproducible on line automated technique to determine endothelial function. Heart (2002) 0.93
Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice. Atherosclerosis (2008) 0.93
Comparison of effect between nitrates and calcium channel antagonist on vascular function in patients with normal or mildly diseased coronary arteries. Heart Vessels (2008) 0.92
Regional coronary endothelial function is closely related to local early coronary atherosclerosis in patients with mild coronary artery disease: pilot study. Circ Cardiovasc Imaging (2012) 0.92
Free radical production by dysfunctional eNOS. Heart (2004) 0.92
Metagenomic analysis of nitrate-reducing bacteria in the oral cavity: implications for nitric oxide homeostasis. PLoS One (2014) 0.91
Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment. Rev Diabet Stud (2013) 0.91
Acute and chronic effects of exercise on circulating endothelial progenitor cells in healthy and diseased patients. Clin Res Cardiol (2012) 0.91
Vascular smooth muscle responsiveness to nitric oxide is reduced in healthy adults with increased adiposity. Am J Physiol Heart Circ Physiol (2012) 0.91
Dairy and cardiovascular health: Friend or foe? Nutr Bull (2014) 0.91
Novel functional risk factors for the prediction of cardiovascular events in vulnerable patients following acute coronary syndrome. Circ J (2012) 0.90
Association between the female athlete triad and endothelial dysfunction in dancers. Clin J Sport Med (2011) 0.89
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature (1999) 13.73
Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res (2001) 8.62
HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest (2001) 4.11
Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation (2003) 2.97
Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation (2001) 2.95
Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med (1997) 2.76
Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circ Res (1998) 2.70
Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet (1992) 2.66
Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet (1997) 2.36
Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation (2000) 2.18
Quantitative assessment of coronary vasoreactivity in humans in vivo. Importance of baseline vasomotor tone in atherosclerosis. Circulation (1995) 2.16
Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Mol Cell Biol (2000) 2.07
Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J Exp Med (1999) 1.99
Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol Cell Biol (2001) 1.98
Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett (2000) 1.97
Akt takes center stage in angiogenesis signaling. Circ Res (2000) 1.96
Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem (1999) 1.78
Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res (2000) 1.73
Nitric oxide-an endothelial cell survival factor. Cell Death Differ (1999) 1.70
Shear stress inhibits apoptosis of human endothelial cells. FEBS Lett (1996) 1.58
Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circ Res (2000) 1.52
Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells. Arterioscler Thromb Vasc Biol (2000) 1.50
Effect of statin therapy on restenosis after coronary stent implantation. Am J Cardiol (2000) 1.50
Ubiquitin-mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction. J Biol Chem (2000) 1.45
Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy. Circulation (2000) 1.44
Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res (2001) 1.44
Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the Pl(A2)allele of the platelet glycoprotein IIIa gene. Eur Heart J (2001) 1.42
Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res (1997) 1.41
Apoptosis of endothelial cells. Contribution to the pathophysiology of atherosclerosis? Eur Cytokine Netw (1998) 1.35
Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide (1997) 1.33
Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. Circulation (1997) 1.31
Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells. Arterioscler Thromb Vasc Biol (1999) 1.31
Nitric oxide activates telomerase and delays endothelial cell senescence. Circ Res (2000) 1.29
Cardiovascular risk factors in primary care: methods and baseline prevalence rates--the DETECT program. Curr Med Res Opin (2005) 1.29
Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol (2001) 1.28
Shear stress inhibits H2O2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase. Arterioscler Thromb Vasc Biol (1997) 1.26
Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol. J Am Coll Cardiol (2000) 1.22
Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway. Circulation (2001) 1.18
Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation (2001) 1.17
Flow-dependent coronary artery dilatation in humans. Circulation (1989) 1.16
TNFalpha and oxLDL reduce protein S-nitrosylation in endothelial cells. J Biol Chem (2001) 1.15
Nitric oxide down-regulates MKP-3 mRNA levels: involvement in endothelial cell protection from apoptosis. J Biol Chem (2000) 1.13
Cyclosporin A inhibits apoptosis of human endothelial cells by preventing release of cytochrome C from mitochondria. Circulation (1998) 1.11
Apoptosis in the vascular wall and atherosclerosis. Basic Res Cardiol (2001) 1.11
Coronary stent grafts covered by a polytetrafluoroethylene membrane. Am J Cardiol (1999) 1.09
Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors. Regul Pept (2000) 1.08
Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation (2002) 1.06
Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany. Atherosclerosis (2006) 1.05
Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. Eur J Pharmacol (1996) 1.05
Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett (2001) 1.04
Co-expression of p53 and MDM2 in human atherosclerosis: implications for the regulation of cellularity of atherosclerotic lesions. J Pathol (1998) 1.04
Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation (2001) 1.03
Upregulation of TRAF-3 by shear stress blocks CD40-mediated endothelial activation. J Clin Invest (2001) 1.00
Inhibition of caspase-3 improves contractile recovery of stunned myocardium, independent of apoptosis-inhibitory effects. J Am Coll Cardiol (2001) 1.00
Nitric oxide and apoptosis. Vitam Horm (1999) 1.00
Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol (2001) 0.97
Endothelial vasodilator dysfunction: pathogenetic link to myocardial ischaemia or epiphenomenon? Lancet (1996) 0.97
Atherosclerosis-associated endothelial dysfunction. Z Kardiol (2000) 0.96
Cystic medial degeneration of the aorta is associated with p53 accumulation, Bax upregulation, apoptotic cell death, and cell proliferation. Heart (1999) 0.94
A positive family history of premature coronary artery disease is associated with impaired endothelium-dependent coronary blood flow regulation. Circulation (1999) 0.94
Growth factor-induced phosphoinositide 3-OH kinase/Akt phosphorylation in smooth muscle cells: induction of cell proliferation and inhibition of cell death. Cardiovasc Res (2000) 0.93
Progression of coronary endothelial dysfunction in man and its potential clinical significance. Basic Res Cardiol (1991) 0.92
Laminar shear stress upregulates integrin expression: role in endothelial cell adhesion and apoptosis. Circ Res (2000) 0.92
Topographical association between the cyclin-dependent kinases inhibitor P21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue. Arterioscler Thromb Vasc Biol (1997) 0.91
Inhibition of endogenous nitric oxide synthase potentiates ischemia-reperfusion-induced myocardial apoptosis via a caspase-3 dependent pathway. Cardiovasc Res (2000) 0.90
Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options. J Intern Med (1999) 0.89
Normalization of coronary blood flow in the infarct-related artery after intracoronary progenitor cell therapy: intracoronary Doppler substudy of the TOPCARE-AMI trial. Clin Res Cardiol (2006) 0.88
Argatroban for elective percutaneous coronary intervention: the ARG-E04 multi-center study. Int J Cardiol (2010) 0.88
[Transesophageal echo computer tomography (ECHO-CT): a new method of dynamic 3-D reconstruction of the heart]. Biomed Tech (Berl) (1989) 0.88
Nitric oxide inhibits APO-1/Fas-mediated cell death. Cell Growth Differ (1998) 0.86
Severity of coronary artery stenosis is associated with a polymorphism in the CXCL16/SR-PSOX gene. J Intern Med (2005) 0.85
[Cardiovascular high-risk constellations in primary care. DETECT Study 2003]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2005) 0.85
Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation. J Am Coll Cardiol (2001) 0.83
Effects of redox-related congeners of NO on apoptosis and caspase-3 activity. Nitric Oxide (1997) 0.83
Treatment of aortocoronary vein graft lesions with membrane-covered stents: A multicenter surveillance trial. Circulation (2000) 0.82
Prognostic implications of endothelial dysfunction: does it mean anything? Coron Artery Dis (2001) 0.82
Torsade de pointes tachycardia as a rare manifestation of acute enteroviral myocarditis. Heart (2001) 0.82
[Treatment costs in a medical intensive care unit: a comparison of 1992 and 1997]. Dtsch Med Wochenschr (1998) 0.81
Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolemia. Hypertension (1991) 0.81
Concordant upregulation of type II-TGF-beta-receptor, the cyclin-dependent kinases inhibitor P27Kip1 and cyclin E in human atherosclerotic tissue: implications for lesion cellularity. Atherosclerosis (1999) 0.81
Endothelial dysfunction in acute coronary syndromes: association with elevated C-reactive protein levels. Ann Med (2000) 0.80
[Psychocardiology today]. Herz (2001) 0.80
Digital angiographic assessment of the physiological changes to the regional microcirculation induced by successful coronary angioplasty. Circulation (1994) 0.79
NADH/NADPH oxidase p22 phox gene polymorphism is associated with improved coronary endothelial vasodilator function. Eur Heart J (2001) 0.79
Laminar shear stress upregulates the complement-inhibitory protein clusterin : a novel potent defense mechanism against complement-induced endothelial cell activation. Circulation (2000) 0.79
[Perforation and rupture of coronary arteries]. Herz (1998) 0.79
Endothelin-1-like immunoreactivity in human atherosclerotic coronary tissue: a detailed analysis of the cellular distribution of endothelin-1. J Pathol (1996) 0.78
Lipoprotein(a) selectively impairs receptor-mediated endothelial vasodilator function of the human coronary circulation. J Am Coll Cardiol (1997) 0.78
Alterations of coronary blood flow and myocardial perfusion in hypercholesterolaemia. Heart (1996) 0.78
Arterial dilatory reserve in congestive heart failure. J Hypertens Suppl (1992) 0.78
Prognostic significance of coronary flow reserve on left ventricular ejection fraction in cardiac transplant recipients. Transplantation (1998) 0.78
Diabetes and cardiovascular risk evaluation and management in primary care: progress and unresolved issues - rationale for a nationwide primary care project in Germany. Exp Clin Endocrinol Diabetes (2004) 0.77
[Determinants of treatment costs of unstable angina pectoris]. Z Kardiol (1999) 0.77
Adjunctive intracoronary urokinase therapy during percutaneous transluminal coronary angioplasty. Am J Cardiol (1996) 0.76
[Diabetes mellitus and coronary artery disease--a high risk combination]. Clin Res Cardiol (2006) 0.76
Effects of inhibition of nitric oxide formation on the regulation of coronary blood flow in anesthetized dogs. Basic Res Cardiol (1996) 0.76